Oren Cohen, president of clinical pharmacology of clinical research organisation (CRO) Fortrea says that it is all good and well asking sponsors to improve the diversity of patients, but sponsors ...

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the ...

Called Evinova, the new unit has emerged with alliances already in place with contract research organisations Parexel and Fortrea ... design and planning of new clinical trials, drawing on ...

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization ... complex randomization and optimize the trial drug supply process, while minimizing operational ...

Fortrea, Veeva and Advarra in pact to streamline clinical trials Through Advarra’s platform, both sponsors and sites can see the entire study startup workflow using their own credentials ...

Fortrea, Lonza, Medpace, Parexel International Corp, Samsung Biologics, Syneos Health, Thermo Fisher Scientific, and WuXi AppTec dominate the market. These companies offer end-to-end solutions, from ...

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.

DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth ...